Strategies for Identifying Hereditary Nonpolyposis Colon Cancer

Seminars in Oncology

Volumn 34, Issue 5, 2007, Pages 411-417

  Evans, D Gareth ^a   Walsh, Sheila ^b   Hill, James ^c   McMahon, Raymond T ^c,d  

^a ST MARY S HOSPITAL   (United Kingdom)

^b TRAFFORD GENERAL HOSPITAL   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT CANCER; CANCER SCREENING; COLONOSCOPY; ENDOMETRIUM CANCER; FAMILIAL CANCER; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GLIOMA; HEREDITARY NONPOLYPOSIS COLON CANCER; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; LOSS OF ANTIBODY STAINING; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MMR GENE; OVARY CANCER; PARAMETER; PATIENT SELECTION; POLYPECTOMY; PRIORITY JOURNAL; STOMACH CANCER; URETER CANCER;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICROSATELLITE INSTABILITY; MUTATION;

EID: 34848921450     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.07.001     Document Type: Article

References (43)

1. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54 (1993) 594-606
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 56 (2006) 106-130
3. Hayne D., Brown R.S.D., McCormack M., et al. Current trends in colorectal cancer: Site, incidence, mortality and survival in England and Wales. Clin Oncol (R Coll Radiol) 13 (2001) 448-452
4. Jarvinen H., Mecklin J.P., and Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 108 (1995) 1405-1411
5. Souza R.F. A molecular rationale for the how, when and why of colorectal cancer of screening. Aliment Pharmacol Ther 15 (2001) 451-462
6. Hemminki K., Lonnstedt I., Vaittinen P., et al. Estimation of genetic and environmental components in colorectal and lung cancer and melanoma. Genetic Epidemiol 20 (2001) 107-116
7. Schoen R.E. Families at risk for colorectal cancer. J Clin Gastroenterol 31 (2000) 114-120
8. Warthin A. Hereditary with reference to carcinoma. Arch Intern Med 12 (1913) 546-555
9. Vasen H.F., Watson P., Mecklin J.P., et al. New clinical criteria for hereditary non polyposis colon cancer (HNPCC, Lynch syndrome) proposed by the International collaborative group on HNPCC. Gastroenterology 116 (1999) 1453-1456
10. Fuchs C.S., Giovannuci E.L., Colditz G.A., et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331 (1994) 1669-1674
11. Evans D.G., Walsh S., Jeacock J., et al. The incidence of hereditary non-polyposis colorectal cancer in a population based study of 1137 consecutive cases of colorectal cancer. Br J Surg 84 (1997) 1281-1285
12. Aarnio M., Sankila R., Pukkala E., et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81 (1999) 214-218
13. Dunlop M.G., Farrington S.M., Carothers A.D., et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6 (1997) 105-110
14. Jarvinen H.J., Aarnio M., Mustonen H., et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colon cancer. Gastroenterology 118 (2000) 829-834
15. Hill J., Walsh S., and Evans D.G. Screening of patients at high risk of colorectal cancer. Colorectal Dis 3 (2001) 308-311
16. Pinol V., Castells A., Andreu M., et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293 (2005) 1986-1994
17. Evans D.G., Lalloo F., Mak A., et al. Is it time to abandon microsatellite instability as a pre-screen for selecting families for mutation testing for mismatch repair genes?. J Clin Oncol 24 (2006) 1960-1962
18. Park J.G., Vasen H.F., Park Y.J., et al. Suspected HNPCC and Amsterdam criteria II: Evaluation of mutation detection rate, an international collaborative study. Int J Colorectal Dis 17 (2002) 109-114
19. Barnetson R.A., Tenesa A., Farrington S.M., et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354 (2006) 2751-2763
20. Boland C.R., Thibodeau S.N., Hamilton S.R., et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 (1998) 5248-5257
21. Calistri D., Presciuttini S., Buonsanti G., et al. Microsatellite instability in colorectal cancer patients with suspected genetic predisposition. Int J Cancer 849 (2000) 87-91
22. Southey M.C., Jenkins M.A., Mead L., et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early onset colorectal cancer. J Clin Oncol 23 (2005) 1-6
23. Wahlberg S.S., Schmeits J., Thomas G., et al. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 62 (2002) 3485-3492
24. Pinol V., Castells A., Andreu M., et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293 (2005) 1986-1994
25. Evans D.G., Wu C.L., Walsh S., et al. Characterisation of hereditary nonpolyposis colon cancer families: population based series of cases. J Natl Cancer Inst 93 (2001) 716-717
26. Salovaara R., Loukola A., Kristo P., et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18 (2000) 2193-2200
27. de Leon M.P., Pedroni M., Benatti P., et al. Hereditary colorectal cancer in the general population: From cancer registration to molecular diagnosis. Gut 45 (1999) 32-38
28. Katballe N., Christensen M., Wikman F.P., et al. Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut 50 (2002) 43-51
29. Percesepe A., Borghi F., Menigatti M., et al. Molecular screening for hereditary nonpolyposis colorectal cancer: A prospective, population-based study. J Clin Oncol 19 (2001) 3944-3950
30. Hampel H., Frankel W.L., Martin E., et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352 (2005) 1851-1860
31. Kievit W., de Bruin J.H., Adang E.M., et al. Cost effectiveness of a new strategy to identify HNPCC patients. Gut 54 (2005) 97-102
32. Ramsey S.D., Clarke L., Etzioni R., et al. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 135 (2001) 577-588
33. Reyes C.M., Allen B.A., Terdiman J.P., et al. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: Effectiveness and cost-effectiveness. Cancer 95 (2002) 1848-1856
34. Chen S., Wang W., Lee S., et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296 (2006) 1479-1487
35. Marroni F., Pastrello C., Benatti P., et al. A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. Clin Genet 69 (2006) 254-262
36. Balmana J., Stockwell D.H., Steyerberg E.W., et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 296 (2006) 1469-1478
37. Hampel H., Frankel W., Panescu J., et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66 (2006) 7810-7817
38. Ericson K.M., Isinger A.P., Isfoss B.L., et al. Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma. BMC Cancer 5 (2005) 23
39. Taylor C.F., Charlton R.S., Burn J., et al. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: Identification of novel and recurrent deletions by MLPA. Hum Mutat 22 (2003) 428-433
40. Grabowski M., Mueller-Koch Y., Grasbon-Frodl E., et al. Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families. Genet Test 9 (2005) 138-146
41. Bunyan D.J., Eccles D.M., Sillibourne J., et al. Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91 (2004) 1155-1159
42. Domingo E., Laiho P., Ollikainen M., et al. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 41 (2004) 664-668
43. Ramsey S.D., Burke W., and Clarke L. An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer. Genet Med 5 (2003) 353-363